«John Dobak had learned about genomic testing in the 1990s and been tracking the evolution of this new approach to detecting cancer, and other diseases. Yet few had been able to turn it into an easy to use diagnostic tool. In 2011, Dobak decided he would take the risk, focusing on genomic testing for melanoma, a cancer that is expected to affect about 100,000 Americans this year.»

«Before this, no one was really looking at the root cause of melanoma and why these cells were turning cancerous. But, with decades of research, through the work done in genomic testing, we now know that changes in the genome are occurring, and if we can see that, we can see if it’s cancerous or not.»

Article written by Esha Chhabra